Impact of a prophylactic quadrivalent human papillomavirus (types 6,11, 16, 18) L1 virus-like particle vaccine in a sexually active populationof North American women |
Barr, E.;Gause, C.K.;Bautista, O.M.;Railkar, R.A.;Lupinacci, L.C.;Insinga, R.P.;Sings, H.L.;Haupt, R.M.; |
American Journal of Obstetrics and Gynecology |
2008-03-01 |
查看 |